The meniscus is a fibrocartilaginous tissue that contributes to several critical functions within the knee joint, such as load bearing ([@b1]), shock absorption ([@b2]), and joint stability. A meniscal tear is one of the most common injuries of the knee joint, primarily due to sports injuries or degenerative conditions ([@b3],[@b4]). Suture repair of meniscus tears is recommended when feasible to preserve the function of meniscal tissue. However, suture repair is typically only suitable for acute tears that have a longitudinal orientation, although repairs of other more complex acute tears can be selectively performed ([@b5],[@b6]). Meniscectomy (partial or total) is the most common arthroscopic procedure performed on the knee joint ([@b7]), but it is correlated with a degenerative change in the articular cartilage and the progression of osteoarthritis ([@b4],[@b8]). It has been reported that meniscal allograft transplantation can provide improvements in pain and function in the short and intermediate term. However, the effects of allografts on the prevention of joint degeneration are still unknown ([@b9],[@b10]), and the use of allograft menisci have not been approved in several countries, including Japan. The development of synthetic meniscus transplant technology is ongoing and has been met with variable degrees of success to date ([@b11]--[@b13]).

Autologous tendon grafts are one of the materials used for meniscal reconstruction ([@b14],[@b15]). A tendon graft offers the advantages of safety, utility, and biologic properties similar to the peripheral half of the native meniscus ([@b16]). In a sheep model, the patellar tendon graft became similar to the original meniscus at 12 months after transplantation. However, in a human clinical study, meniscal reconstruction with semitendinosus tendon or patellar tendon graft has not yet been shown to prevent the progression of cartilage degeneration ([@b15]).

The outcome of tendon transplantation for meniscal defect may be improved by additional procedures, one of which is the use of growth factors. Bone morphogenetic protein 7 (BMP-7) is currently used to accelerate bone union for delayed union of fractures in clinical situations ([@b17]--[@b19]). Recent studies have demonstrated that weekly intraarticular injection of a low dose of BMP-7 prevented the degenerative changes common to cartilage in an experimental osteoarthritis model and in an inflammatory arthritis model, without inducing ectopic ossification ([@b20]--[@b22]). These results indicate that BMP-7 may promote cartilage formation rather than bone formation in joint conditions. The purposes of this study were 1) to examine whether BMP-7 induces ectopic cartilage formation in tendon, 2) to investigate whether the transplantation of tendon treated with BMP-7 promotes meniscal regeneration, and 3) to analyze the relative contribution of host and donor tissue on the healing process after tendon transplantation in a rat model.

MATERIALS AND METHODS
=====================

Animals
-------

Wild-type male Lewis rats (Charles River Japan) and LacZ-expressing--transgenic rats ([@b23]) (provided by Jichi Medical University, Tochigi, Japan) ages 10--12 weeks were used for the experiments. Rats were anesthetized by isoflurane inhalation and intraperitoneal injection of tribromoethanol. All animal care and experiments were conducted in accordance with the institutional guidelines of the Animal Committee of Tokyo Medical and Dental University.

In situ BMP-7 injection into the rat Achilles tendon
----------------------------------------------------

A straight skin incision was made to expose the Achilles tendon, followed by an injection of 0.1, 0.5, or 1 μg of BMP-7 (Stryker Biotech) in 10 μl of phosphate buffered saline (PBS) with a 31-gauge needle ([Figure 1](#fig01){ref-type="fig"}A). After closure of the incision, the rats were allowed to walk freely in their cages and were then killed at 2, 3, or 4 weeks for evaluation of ectopic cartilage formation.

![Effect of in situ bone morphogenetic protein 7 (BMP-7) injection into the rat Achilles tendon. A, Procedure used to inject BMP-7 into the rat Achilles tendon. B, Histologic examination of rat Achilles tendon stained with Safranin O and immunostained with type I and type II collagen. Arrows indicate ectopic chondrocyte formation. C, Dendrogram generated from microarray analysis of native rat tendon, rat tendon treated with 1 μg of BMP-7 4 weeks before analysis, native rat meniscus, and native rat articular cartilage (AC) with subchondral bone. D, Results of polymerase chain reaction analysis of aggrecan, *Col1a1*, and *Col2a1*. Bars show the mean ± SD expression level relative to the expression level in native tendon (n = 4 rats per group). ∗ = *P* \< 0.05 by Kruskal-Wallis test.](art0065-2876-f1){#fig01}

Oligonucleotide microarray
--------------------------

RNA was isolated from normal rat tendon, normal rat meniscus, normal rat articular cartilage with subchondral bone, and rat tendon treated with BMP-7 which had been injected in situ 4 weeks prior (n = 4 rats per group), using TRIzol solution (Invitrogen Life Technologies) and cleaned using a High Pure RNA Isolation kit (Roche Applied Sciences). A microarray analysis was performed using 3 μg of total RNA from each sample, and GeneChip Rat Genome 230 2.0 probe arrays (Affymetrix) according to the manufacturer\'s instructions ([@b24]). Data were analyzed with GeneSpring GX software version 7.3.1 (Agilent Technologies). To normalize the variations in staining intensity among chips, the signal values for all genes on a given chip were divided by the median value for the expression of all genes on the chip. To eliminate genes containing only a background signal, genes were selected only if the raw values of the signal were more than the lower limit of the confidence interval and expression of the gene was judged to be "present" by GeneChip Operating Software version 1.4 (Affymetrix). The microarray data were deposited in the Gene Expression Omnibus ([@b25]) (GEO accession no. GSE24612). Genes that met these quality criteria were subjected to further analysis. An unsupervised hierarchical clustering analysis was performed using a minimum distance value of 0.001, a separation ratio of 0.5, and the standard definition of the correlation distance. A dendrogram was obtained from hierarchical clustering analysis using average linkage and a distance metric equal to 1 minus the Pearson correlation coefficient applied to the microarray data.

Real-time quantitative polymerase chain reaction (qPCR)
-------------------------------------------------------

First-strand complementary DNAs (cDNAs) were synthesized using a Transcriptor First-Strand cDNA synthesis kit (Roche), and qPCR analyses were performed using a LightCycler 480 Probe Master system (Roche). β-actin was used as an internal control. Relative messenger RNA expression levels were calculated as described by Niikura et al ([@b26]). PCR primers were as follows: for aggrecan, 5′-GCAGGGATAACGGACTGAAG-3′ (forward) and 5′-GAGTAAAGTGGTCATAGTTCAGCTTG-3′ (reverse); for COL1A1, 5′-TCCTGGCAAGAACGGAGAT-3′ (forward) and 5′-CAGGAGGTCCACGCTCAC-3′ (reverse); for COL2A1, 5′-CCAGGTCCTGCTGGAAAA-3′ (forward) and 5′-CCTCTTTCTCCGGCCTTT-3′ (reverse). Data are expressed as the fold change relative to native tendon.

Transplantation of autologous rat Achilles tendon treated with BMP-7
--------------------------------------------------------------------

Achilles tendon was harvested from the right paw and molded into a similar size as the meniscus with both ends ligated by 6-0 nylon sutures. The left knee joint was exposed with a straight skin incision on the anterior side of the knee. After the patellar tendon was dislocated laterally and the anterior insertional ligament of the medial meniscus was transected, the anterior half of the medial meniscus was dislocated and resected at the level of the medial collateral ligament. Then, 1 μg of BMP-7 in 10 μl of PBS was injected with a 31-gauge needle into the prepared Achilles tendon, and the tendon was transplanted into the meniscal defect and sutured with the capsule and medial collateral ligament with 6-0 nylon sutures. The rats were allowed to walk freely in their cages and then killed at 4, 8, or 12 weeks (BMP-7--treated tendon group; n = 6). The same numbers of rats underwent transplantation surgery with Achilles tendon untreated with BMP-7 (tendon group; n = 6) or meniscectomy only (untreated group; n = 6).

Transplantation of Achilles tendon into the meniscal defect using transgenic rats expressing LacZ
-------------------------------------------------------------------------------------------------

The Achilles tendon from LacZ-expressing--transgenic rats was transplanted into the meniscal defect in wild-type rat knees. Conversely, the Achilles tendon from wild-type rats was transplanted into the meniscal defect in LacZ-expressing--transgenic rat knees. At 4 weeks, the transplanted tendon and surrounding area were evaluated (n = 4 rats per group).

Macroscopic observation
-----------------------

The tibial plateau with menisci was carefully separated from the femoral condyle. Macroscopic pictures were taken using an Olympus MVX10 microscope on a dedicated medical photography platform. Quantification of the size of the regenerated meniscus was performed using AxioVision Rel software version 4.8 to measure the ratio of the whole area of the medial meniscus, including both the regenerated region and the normal region, to the whole area of the medial tibial plateau.

Histologic examination
----------------------

Regenerated rat meniscal tissue and proximal tibia were fixed in 4% paraformaldehyde for 7 days, decalcified in 20% EDTA solution for 10 days or 21 days, respectively, and then embedded in paraffin wax. The specimens were sectioned in the sagittal plane at 5 μm and stained with Safranin O--fast green. Histologic sections were visualized using an Olympus BX53 microscope. Regenerated meniscus was evaluated using the modified Pauli score on a scale of 0--18 points ([@b27]) (see Supplementary Table 1, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/doi/10.1002/art.38099/abstract>). Cartilage degeneration of the medial tibia was evaluated using the Mankin score, on a scale of 0--14 points ([@b28]). As a control, a 22-week-old normal rat was evaluated for both meniscus and cartilage injury.

Immunohistochemistry
--------------------

Paraffin-embedded sections were deparaffinized in xylene, rehydrated in graded alcohol, and washed in PBS. Then the samples were pretreated with 0.4 mg/ml proteinase K (Dako) in Tris HCl buffer for 15 minutes at room temperature for optimal antigen retrieval. All subsequent incubations were performed in a humidified chamber. Endogenous peroxidases were quenched using 0.3% hydrogen peroxidase in methanol for 15 minutes at room temperature. Any residual enzymatic activity was removed by washing with PBS, and nonspecific antigen was blocked by preincubation with PBS containing 10% normal horse serum (Vector) for 20 minutes at 4°C. Primary antibodies (rabbit anti-- type I collagen; 1:200 dilution \[Abcam\] and human anti--type II collagen; 1:200 dilution \[Daiichi Fine Chemical\]) were applied to sections and kept overnight at 4°C for type I collagen and incubated at room temperature for 1 hour for type II collagen. After extensive washes with PBS, the sections were incubated in the secondary antibody biotinylated goat anti-rabbit IgG for type I collagen (1:200 dilution; Vector) or biotinylated horse anti-mouse IgG for type II collagen (1:200 dilution; Vector) for 30 minutes at room temperature. Immunostaining was detected with Vectastain ABC reagent (Vector) followed by diaminobenzidine staining. The sections were counterstained with hematoxylin.

Detection of LacZ expression
----------------------------

After either LacZ-transgenic rats or wild-type rats were killed, the tibial condyle with meniscal tissue was separated from the femoral condyle and fixed with a fixative solution (0.2% glutaraldehyde, 2 m*M* MgCl~2~, and 5 m*M* EDTA) in PBS for 30 minutes at room temperature and rinsed 3 times in PBS to wash out the fixative solution. The tissue was then treated with an X-Gal staining solution (1 mg/ml X-Gal, 2 m*M* MgCl~2~, 6 m*M* potassium ferricyanide, and 6 m*M* potassium ferrocyanide) under incubation at 37°C for 3 hours. Sections were subsequently fixed again in 4% paraformaldehyde, following separation of meniscal tissue from the tibial condyle. The meniscal tissue was decalcified with 0.5*M* EDTA (pH 7.5) for 10 days, and embedded in paraffin wax, following sectioning and counterstaining with eosin.

Statistical analysis
--------------------

StatView 5.0 (SAS Institute) was used for statistical analyses. Non--repeated-measures analysis of variance was performed for analysis of the meniscus covering ratio, and the Kruskal-Wallis test was performed for analysis of PCR results, the modified Pauli score, and the Mankin score. *P* values less than 0.05 were considered significant.

RESULTS
=======

Ectopic fibrocartilage formation in rat Achilles tendons after in situ BMP-7 injections
---------------------------------------------------------------------------------------

BMP-7 was injected into the rat Achilles tendon to examine ectopic fibrochondrocyte formation ([Figure 1](#fig01){ref-type="fig"}A). When 0.1 or 0.5 μg of BMP-7 was injected, slight cartilage matrix staining with Safranin O was first observed 4 weeks after injection ([Figure 1](#fig01){ref-type="fig"}B). When 1 μg of BMP-7 was injected, cartilage matrix staining with Safranin O and immunostaining with type II collagen were first observed 2 weeks after injection, and increased at 3 and 4 weeks. Protein expression of type I collagen did not change with BMP-7 treatment ([Figure 1](#fig01){ref-type="fig"}B). These findings indicate that in situ injection of 1 μg of BMP-7 induced ectopic fibrocartilage formation in the rat Achilles tendon, as demonstrated histologically by increased Safranin O staining ([Figure 1](#fig01){ref-type="fig"}B).

For microarray analysis, we extracted 374 probes (198 genes) with annotation information containing the key word "collagen" from public databases (Ensembl, Entrez Gene, Swiss Prot, EC, OMIM, Gene Ontology, and InterPro) by using GeneSpring software (see Supplementary Table 2, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/doi/10.1002/art.38099/abstract>). Microarray analysis demonstrated that the gene expression related to collagens in the rat tendon treated with BMP-7 was more similar to that in native meniscus than to that in native tendon or articular cartilage with subchondral bone ([Figure 1](#fig01){ref-type="fig"}C) (see Supplementary Tables 2 and 3, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/doi/10.1002/art.38099/abstract>). PCR analysis revealed that the expression of *Col2a1* was significantly more up-regulated in rat tendon treated with BMP-7 than in native tendon, and *Col2a1* expression levels in BMP-7--treated tendon were similar to those in native meniscus and articular cartilage with subchondral bone ([Figure 1](#fig01){ref-type="fig"}D).

Promotion of meniscal regeneration by transplantation of rat Achilles tendon treated with BMP-7
-----------------------------------------------------------------------------------------------

We next investigated the effectiveness of the transplantation of autologous rat Achilles tendons treated with 1 μg of BMP-7 in a model of massive meniscal defect ([Figures 2](#fig02){ref-type="fig"}A and B). Macroscopically, in the untreated group, the meniscal defect was only filled with synovial tissue 4 and 8 weeks after meniscectomy. Irrespective of BMP-7 treatment, the meniscal defect was repaired as early as 4 weeks after transplantation of Achilles tendon ([Figure 2](#fig02){ref-type="fig"}C), and regenerated tissue was integrated with native meniscus (arrowheads in [Figure 2](#fig02){ref-type="fig"}C). The meniscus covering ratio ([Figure 2](#fig02){ref-type="fig"}D) was smaller in the untreated group than in the other 2 groups 4 and 8 weeks after transplantation ([Figure 2](#fig02){ref-type="fig"}E).

![Macroscopic analyses of transplantation of Achilles tendon treated with bone morphogenetic protein 7 (BMP-7) into meniscal defects in rats. A, Study scheme. B, Procedure used for the surgery. The anterior half of the medial meniscus was resected (untreated group), then transplantation of Achilles tendon was performed (tendon group). In the third group, Achilles tendon was transplanted just after injection of BMP-7 (tendon + BMP-7 group). BMP-7 solution with dying agent is indicated in blue. C, Macroscopic features. Arrows indicate the resected site; arrowheads indicate integration sites of regenerated tissue and native meniscus. D, Method of determining the "meniscus covering ratio," defined as the ratio of medial meniscus area to medial plateau area. E, Meniscus covering ratio. Bars show the mean ± SD (n = 6 rats per group). ∗ = *P* \< 0.05 by non--repeated-measures analysis of variance. NS = not significant. Color figure can be viewed in the online issue, which is available at <http://onlinelibrary.wiley.com/doi/10.1002/acr.38099/abstract>.](art0065-2876-f2){#fig02}

Histologically, at 4 weeks, coarse tissue was observed in the untreated rats and tendon tissue was observed in the rats that received transplantation of untreated Achilles tendon. Matrix stained with Safranin O and immunostained with type II collagen was observed in the central portion of the regenerated meniscus at 4 weeks in the rats that received transplantation of BMP-7--treated tendon ([Figures 3](#fig03){ref-type="fig"}A and [4](#fig04){ref-type="fig"}), whereas matrix immunostained with type II collagen increased at 8 weeks in the rats that received untreated tendon and at 12 weeks in the untreated group. Lacuna formation was observed at 12 weeks in the rats that received BMP-7--treated tendon, and the morphology of the cells became closer to that of normal meniscal cells. In the regenerated meniscus, increased matrix staining with Safranin O was more apparent in the inner zone than in the outer zone, though the morphology of the cells was similar ([Figure 3](#fig03){ref-type="fig"}A, broken line). The pattern of distribution of type I collagen was nearly identical between the rats that received BMP-7--treated tendon and the normal group at 12 weeks ([Figure 4](#fig04){ref-type="fig"}). An improved modified Pauli score was observed in the rats that received BMP-7--treated tendon compared to the untreated group at 4, 8, and 12 weeks ([Figure 3](#fig03){ref-type="fig"}B).

![Histologic analysis of regenerated rat meniscus. A, Sections from untreated rats, rats that received transplantation of untreated Achilles tendon (tendon), and rats that received transplantation of bone morphogenetic protein 7 (BMP-7)--treated Achilles tendon (tendon + BMP-7), stained with Safranin O 4 weeks, 8 weeks, and 12 weeks after surgery. The boxed areas in the insets are shown at a higher-magnification view in the larger panels. Broken lines indicate the outer zone of the regenerated meniscus in a rat that received BMP-7--treated tendon. B, Modified Pauli scores for histology. Bars show the mean ± SD (n = 6 rats per group). ∗ = *P* \< 0.05 by Kruskal-Wallis test. Color figure can be viewed in the online issue, which is available at <http://onlinelibrary.wiley.com/doi/10.1002/acr.38099/abstract>.](art0065-2876-f3){#fig03}

![Immunohistochemical analysis for type I collagen and type II collagen in the regenerated meniscus of normal rats, rats that received transplantation of bone morphogenetic protein 7 (BMP-7)--treated tendon (tendon + BMP-7), rats that received transplantation of untreated tendon (tendon), and untreated rats, 4 weeks, 8 weeks, and 12 weeks after surgery. The boxed areas in the insets are shown at a higher-magnification view in the larger panels. Color figure can be viewed in the online issue, which is available at <http://onlinelibrary.wiley.com/doi/10.1002/acr.38099/abstract>.](art0065-2876-f4){#fig04}

While cartilage degeneration was observed as early as 4 weeks after meniscectomy in the untreated group, it was nearly absent in the other 2 groups ([Figure 5](#fig05){ref-type="fig"}A). Though cartilage degeneration progressed further thereafter in all of the groups, the Mankin score at 12 weeks was best in the rats that received BMP-7--treated tendon ([Figure 5](#fig05){ref-type="fig"}B). These results indicate that transplantation of rat Achilles tendon treated with BMP-7 promoted meniscal regeneration and delayed cartilage degeneration.

![Histologic analysis of rat articular cartilage at the medial tibial plateau. A, Sagittal sections from untreated rats, rats that received transplantation of untreated Achilles tendon (tendon), and rats that received transplantation of bone morphogenetic protein 7 (BMP-7)--treated Achilles tendon (tendon + BMP-7), stained with Safranin O 4 weeks, 8 weeks, and 12 weeks after surgery. A section from a 22-week-old normal rat was used as a control. Boxed areas in the top panels are shown at a higher-magnification view in the bottom panels. B, Mankin scores. Bars show the mean ± SD (n = 6 rats per group). ∗ = *P* \< 0.05 by Kruskal-Wallis test. NS = not significant. Color figure can be viewed in the online issue, which is available at <http://onlinelibrary.wiley.com/doi/10.1002/acr.38099/abstract>.](art0065-2876-f5){#fig05}

Detection of donor rat tendon cells and host rat synovial cells in and around the transplanted tendon
-----------------------------------------------------------------------------------------------------

Finally, to analyze the relative contributions of host and donor tendon cells to the healing process after tendon transplantation, we used transgenic rats expressing LacZ. When the Achilles tendon of LacZ-transgenic rats was transplanted into the meniscal defect in wild-type rat knees ([Figure 6](#fig06){ref-type="fig"}A), LacZ expression was still detected in transplanted tissue macroscopically ([Figure 6](#fig06){ref-type="fig"}B, left panel) and histologically ([Figure 6](#fig06){ref-type="fig"}B, right panel) 4 weeks after transplantation, though the LacZ-positive area was decreased.

![A, Illustration of transplantation of Achilles tendon from a LacZ-transgenic rat into the meniscus of a wild-type rat. B, Macroscopic (left) and histologic (right) analysis of sections from a wild-type rat that received transplantation of Achilles tendon from a LacZ-transgenic rat. Macroscopic features of the tibial plateau with medial and lateral menisci 4 weeks after transplantation are shown. Whole tissue was stained with X-Gal. Arrow indicates the LacZ-positive area. Histologic analysis showed LacZ-positive cells (blue) in transplanted tendon at 4 weeks. The boxed area in the inset is shown at a higher-magnification view in the larger panel. C, Illustration of transplantation of Achilles tendon from a wild-type rat into the meniscus of a LacZ-transgenic rat. D, Macroscopic (left and middle) and histologic (right) analysis of sections from a LacZ-transgenic rat that received transplantation of Achilles tendon from a wild-type rat. Macroscopic features of the medial tibial plateau left unstained (left) or stained with X-Gal (middle) 4 weeks after transplantation are shown. Arrows indicate the transplantation site. Histologic analysis of transplanted tendon stained with X-Gal was performed at 4 weeks. The boxed area in the inset is shown at a higher-magnification view in the larger panel. E, Possible mechanism of meniscus regeneration by transplantation of Achilles tendon treated with bone morphogenetic protein 7 (BMP-7) in a rat model of massive meniscal defect. In the untreated group, only a small amount of synovium filled the space of the meniscal defect, and it did not mature into meniscus. In the rats that received transplantation of untreated tendon, the transplanted tendon played the role of scaffold, synovium covered the tendon, and both promoted meniscus regeneration. In the rats that received transplantation of tendon treated with BMP-7, in addition to the effect of tendon transplantation, BMP-7 induced chondrocyte differentiation of tendon cells, and consequently menicsus regeneration was enhanced. Color figure can be viewed in the online issue, which is available at <http://onlinelibrary.wiley.com/doi/10.1002/acr.38099/abstract>.](art0065-2876-f6){#fig06}

When the Achilles tendon of wild-type rats was transplanted into meniscal defects in LacZ-transgenic rats ([Figure 6](#fig06){ref-type="fig"}C), tissue derived from the LacZ host rats was stained with X-Gal macroscopically 4 weeks after transplantation ([Figure 6](#fig06){ref-type="fig"}D, left and middle panels). Histologically, in the LacZ host rat, the LacZ-positive cells were detected within the synovial tissue, which covered the transplanted tendon ([Figure 6](#fig06){ref-type="fig"}D, right panel).

DISCUSSION
==========

In this study, the transplantation of Achilles tendon into meniscal defects in rats regenerated tissue that covered the tibial plateau more effectively than tissue in untreated defects. When BMP-7 was injected into the rat tendon before transplantation, the matrix of the regenerated meniscus increased, as indicated by Safranin O and type II collagen staining, and articular cartilage degeneration was delayed.

It is well known that BMPs induce ectopic ossification in adults ([@b29]) and induce ectopic cartilage formation during development ([@b30],[@b31]). In this study, we demonstrated that the in situ injection of BMP-7 induced ectopic fibrocartilage formation in the rat Achilles tendon and changed the collagen gene profile to more closely resemble meniscal tissue than tendon tissue. Questions remain as to whether the fibrocartilage formation further progresses toward ossification, whether other BMPs could have similar effects, and whether there are dose-response effects when using doses outside of the range we tested. We do not have the answers to all of these questions at present, but the ectopic fibrocartilage formation observed was promisingly generated in tendon tissue using the experimental conditions described and was the rationale for transplanting the fibrocartilaginous tissue into the meniscal defect in experiments performed thereafter.

For meniscus regeneration or the enhancement of meniscus repair, many approaches using scaffolds, cells, and/or growth factors have been described ([@b11],[@b12],[@b32]--[@b35]). One method for repair is tendon graft substitution, but it has not previously shown positive results without further modification ([@b14],[@b15]). BMP-7 is a critical factor for the development of skeletal growth ([@b36]) and plays important roles in the homeostasis of cartilage and in cartilage repair ([@b37]--[@b40]). Also, BMP-7 has been shown to be safe for use in humans with its clinical application in the delayed union of bone fractures ([@b17],[@b19]). Therefore, we examined the effect of BMP-7 on the enhancement of meniscus regeneration after tendon transplantation.

In this study, we demonstrated that the transplantation of Achilles tendon treated with BMP-7 promoted meniscus regeneration in a rat model of massive meniscal defect and prevented degeneration of articular cartilage. Macroscopically, a greater amount of regenerated meniscus was obtained in the tendon transplantation groups. Histologically, the regenerated meniscus appeared to be most similar to native meniscus in the rats that received transplantation of BMP-7--treated tendon. From these findings, we summarized the possible mechanism of meniscal regeneration in this rat model ([Figure 6](#fig06){ref-type="fig"}E).

When meniscal defects are not treated, seemingly only a small amount of synovial tissue including certain kinds of progenitor cells fills the meniscal defect, but the regenerated tissue is too small and too poor to prevent cartilage degeneration. When tendon is transplanted into meniscal defects, it apparently plays a role as a scaffold for meniscal regeneration from very early stages, and is covered by synovium. However, the tendon fails to convert to the fibrocartilage present in the native meniscus. When tendon treated with BMP-7 is transplanted into a meniscal defect, the tendon serves as a scaffold, and the addition of BMP-7 promotes the fibrocartilage differentiation of tendon cells to enhance matrix synthesis.

For the regenerated meniscus, biomechanical testing was not performed. Therefore, we cannot confirm that the regenerated meniscus has the same biomechanical properties as the normal meniscus, though the histologic features were close to those of the native meniscus. However, transplantation of the Achilles tendon treated with BMP-7 delayed cartilage degeneration when compared to the other 2 groups tested. These chondroprotective features suggest that the biomechanical properties of the regenerated tissue in the rats that received transplantation of BMP-7--treated tendon were closer to those of the native rat meniscus than in the tendon alone and empty defect groups.

One of the limitations of this study is the different properties of the small animal and human meniscus. It has been shown that the meniscus in small animals is more cellular than that of the human meniscus ([@b41]). Distributions of type I and type II collagen are similar but not identical ([@b42],[@b43]). Furthermore, it has been shown that the rat meniscus occasionally ossifies ([@b44]), and our experimental tissue-processing conditions used EDTA, which decalcified the tissues, thereby precluding the detection of any significant ossification. Therefore, the results of our study providing evidence of meniscal regeneration though the procedure must be translated to studies in higher mammalian organisms and human trials, given the species differences in the meniscus, to ensure that the clinically relevant regenerated meniscus in tendons treated with BMP-7 are most similar to that of the native meniscus.

To date, there have been no studies describing cell remodeling experiments to determine the fate of transplanted cells and to identify the relative contributions of host and donor tissue to the healing process in the transplantation of tendon for meniscal defect. Our findings suggest that the cell viability of the transplanted tissue is relevant, which is an important finding, since some of the literature on meniscus transplantation suggests that donor cell viability declines in the weeks after transplantation ([@b45]), though Verdonk et al found that cell viability from the donor tissue remains even up to 1 year after surgery ([@b46]). Controversy remains regarding whether the residual cells within the tendon graft remain alive or disappear in the process of remodeling during autologous anterior cruciate ligament reconstruction ([@b47]).

When the Achilles tendon of LacZ-transgenic rats was transplanted into the meniscal defect in wild-type rat knees in our study, LacZ expression was partially detected in transplanted tissue. This indicates that the original cells within the tendon remained alive and contributed to meniscal regeneration. When the Achilles tendon of wild-type rats was transplanted into meniscal defects in LacZ-transgenic rat knees, transplanted tissue was covered by synovium of LacZ-transgenic rat origin. This indicates that synovial coverage by the host knee joint plays an important role in support of meniscus remodeling and regeneration.

The LacZ-positive area decreased 4 weeks after the Achilles tendon of LacZ-transgenic rats was transplanted into the meniscal defect in wild-type rat knees. The experiment with LacZ-transgenic rats involved a syngeneic transplantation model, and LacZ expression may also have affected immunoreaction. Other studies have used an autologous transplantation model ([@b14],[@b15]). Therefore, contributions of host and donor cells in autologous tendon transplantation may differ from those found in the present study.

In conclusion, we have demonstrated that the transplantation of Achilles tendon treated with BMP-7 promoted meniscus regeneration in a rat model of massive meniscal defect and prevented cartilage degeneration. This may be a promising future procedure for the treatment of meniscal defects.
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